Biomarkers: Potential Uses and Limitations

NeuroRx

Volumn 1, Issue 2, 2004, Pages 182-188

  Mayeux, Richard ^a  

^a Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H Sergievsky Center   (United States)

Author keywords

Antecedent biomarkers; diagnostic biomarkers; reliability; validity; variability

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; CONFOUNDING VARIABLE; DISEASE CLASSIFICATION; DISEASE MARKER; HUMAN; LABORATORY DIAGNOSIS; NEUROLOGIC DISEASE; NEUROPATHOLOGY; RELIABILITY; RISK FACTOR; VALIDITY; MASS SCREENING; METABOLISM; PROGNOSIS; REVIEW;

BIOLOGICAL MARKERS; HUMANS; MASS SCREENING; NERVOUS SYSTEM DISEASES; PROGNOSIS; RISK FACTORS;

EID: 23244465303     PISSN: 15455343     EISSN: 15455351     Source Type: Journal    
DOI: 10.1602/neurorx.1.2.182     Document Type: Article

References (16)

1. Hulka B. Overview of biological markers. In: Hulka B., Griffith J., and Wilcosky T. (Eds). Biological markers in epidemiology (1990), Oxford University Press, New York 3-15
2. Naylor S. Biomarkers: current perspectives and future prospects. Expert Rev Mol Diagn 3 (2003) 525-529
3. Perera F., and Weinstein I. Molecular epidemiology: recent advances and future directions. Carcinogenesis 21 (2000) 517-524
4. Gordis L. Epidemiology and public policy. In: Gordis L. (Ed). Epidemiology (1996), W.B. Saunders, Philadelphia 247-256
5. Verbeek M., De Jong D., and Kremer H. Brain-specific proteins in cerebrospinal fluid for the diagnosis of neurodegenerative diseases. Ann Clin Biochem 40 (2003) 25-40
6. Galasko D. New approaches to diagnose and treat Alzheimer's disease: a glimpse of the future. Clin Geriatr Med 17 (2001) 393-410
7. Rohlff C. Proteomics in neuropsychiatric disorders. Int J Neuropsychopharmacol 4 (2001) 93-102
8. Reiber H., and Peter J. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J Neurol Sci 184 (2001) 101-122
9. Schulte P. A conceptual and historical framework for molecular epidemiology. In: Schulte P., and Perera F. (Eds). Molecular epidemiology: principles and practices (1993), Academic Press, San Diego 3-44
10. Merikangas K. Genetic epidemiology: bringing genetics to the population-the NAPE Lecture 2001. Acta Psychiatr Scand 105 (2002) 3-13
11. Muller U., and Graeber M. Neurogenetic diseases: molecular diagnosis and therapeutic approaches. J Mol Med 74 (1996) 71-84
12. Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci 26 (2003) 81-104
13. Schulte P., and Perera F. Validation. In: Schulte P., and Perera F. (Eds). Molecular epidemiology: principles and practices (1993), Academic Press, San Diego 79-107
14. Pepe M., and Thompson M. Combining diagnostic test results to increase accuracy. Biostatistics 1 (2000) 123-140
15. Thompson M., and Zucchini W. On the statistical analysis of ROC curves. Stat Med 8 (1989) 1277-1290
16. Mayeux R., Saunders A., Shea S., et al. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on apolipoprotein E and Alzheimer's disease. N Engl J Med 338 (1998) 506-511